198 related articles for article (PubMed ID: 2881819)
21. Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers.
Halperin SA; Tapiero B; Law B; Diaz-Mitoma F; Duval B; Langley JM; Elrick DB; Jacquet JM
Vaccine; 2006 May; 24(18):4017-23. PubMed ID: 16516357
[TBL] [Abstract][Full Text] [Related]
22. Immunologic response to early and routine DTP immunization in infants.
Baraff LJ; Leake RD; Burstyn DG; Payne T; Cody CL; Manclark CR; St Geme JW
Pediatrics; 1984 Jan; 73(1):37-42. PubMed ID: 6318185
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
[TBL] [Abstract][Full Text] [Related]
24. Feasible improvements in vaccines in the Expanded Programme on Immunization.
McIntosh K
Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
[TBL] [Abstract][Full Text] [Related]
25. [Tetravalent diphtheria, tetanus, pertussis and inactivated poliomyelitis vaccine].
Fillastre C; Brégère P; Guérin N
Arch Fr Pediatr; 1989 Nov; 46(9):693-700. PubMed ID: 2604532
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
[TBL] [Abstract][Full Text] [Related]
27. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
28. A fourth dose of DTPa-IPV vaccine given to 4-6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11-12 months of age.
Nilsson L; Faldella G; Jacquet JM; Storsaeter J; Silfverdal SA; Ekholm L
Scand J Infect Dis; 2005; 37(3):221-9. PubMed ID: 15849057
[TBL] [Abstract][Full Text] [Related]
29. The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency.
Simoes EA; John TJ
J Biol Stand; 1986 Apr; 14(2):127-31. PubMed ID: 3020057
[TBL] [Abstract][Full Text] [Related]
30. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
[TBL] [Abstract][Full Text] [Related]
31. Age and dose interval as factors in agglutinin formation to pertussis vaccine.
Wilkins J; Chan LS; Wehrle PF
Vaccine; 1987 Mar; 5(1):49-54. PubMed ID: 2883784
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
33. [The epidemic process of diphtheria and pertussis with active immunization of a pediatric population].
Blinova LL
Zh Mikrobiol Epidemiol Immunobiol; 1986 Nov; (11):30-1. PubMed ID: 2879404
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen.
Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
Infect Immun; 1986 Mar; 51(3):784-7. PubMed ID: 2936684
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
[TBL] [Abstract][Full Text] [Related]
36. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
Rümke HC
Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
[No Abstract] [Full Text] [Related]
37. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
[TBL] [Abstract][Full Text] [Related]
38. [The level of postvaccinal immunity to diphtheria, tetanus and poliomyelitis in relation to the number of inoculations].
Chudnaia LM; Oksiiuk VG; Shekhter AB; Krasiuk LS; Afanas'eva SM; Bryzhata SI; Kozhan NE; Chaban EP
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):46-9. PubMed ID: 1650072
[TBL] [Abstract][Full Text] [Related]
39. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
[TBL] [Abstract][Full Text] [Related]
40. Antibody response to measles vaccine with DTPP.
John TJ; Selvakumar R; Balrai V; Simoes EA
Am J Dis Child; 1987 Jan; 141(1):14. PubMed ID: 3491536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
